FAST & Fellows Round Up
Read the latest in FAST and Fellows news:
- Current FAST Fall 2017 company Inflammatix, FAST Grads HepaTx (Spring 2017), X-Therma (Spring 2017), Empire Biotechnologies(Fall 2016), SciBac (Fall 2016), Eidos Therapeutics (Spring 2016), and Magnetic Insight (Spring 2015), presented at BIO Investor Forum in San Francisco.
- FAST Grad Eidos Therapeutics (Spring 2016) initiates Phase 1 trial of of AG10, an orally bioavailable, small molecule stabilizer of transthyretin (TTR) Read More
- FAST Grad Sandstone Diagnostics (Fall 2013) was featured in Newsweek on the problem of declining fertility and what the Trak Male Fertility Testing System is doing to reverse the trend Read More
- Fellows member Synergys Biotherapeutics announced Phase 1 SBIR grant award from NIH for vasculogenic mimicry-blocking antibody fusion products for triple negative breast cancer Read More
To learn more about the CLSA Fellows program – the significantly discounted membership for life science startups – click here.
The FAST (Fellows All-Star Team) Accelerator provides select entrepreneurs with intensive team review and coaching to perfect their business model, product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement, and business development specialists) will advise selected Fellows during a ten-to-twelve week program, culminating in a Final FAST Showcase to a broad audience that includes potential investors and partners.